JAK-Inhibition in Immune-Mediated Diseases (IMiDs)
Earn CME for related activities: https://hmpeducation.com/ In this webcast, Dr. Vibeke Strand discusses the mechanism of action of JAK inhibitors and examines the efficacy, safety, and adverse events associated with this class of small molecule therapeutics.
▶︎
JAK inhibitors in Psoriasis and PsA
▶︎
Atopic Dermatitis: JAK Inhibitors and Beyond
▶︎
Impact of Chorea in HD and the Evolving Treatment Landscape
▶︎
NNPTC National TMVII: Could it Be Ringworm? Webinar
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Anemia (Types, Findings, Lab Values)
▶︎
JAK Inhibition: Are the Promises Fulfilled?
▶︎
The role of JAK inhibitors in your clinical practice
▶︎
Cardiodermatology and Cardiovascular Risk in Inflammatory Skin Disease
▶︎
Unlock Updated Guidelines for the Treatment of RRMM
▶︎
Remission in Dermatology: What Does "Clear" Really Mean for Psoriasis and Atopic Dermatitis?
▶︎
Psoriasis Uncovered: GLP-1 & GIP Therapies: What They Mean for Psoriasis and Psoriatic Arthritis
▶︎
Why Are Prescription Drugs So Costly in the US? | The Other Drug War (full documentary) | FRONTLINE
▶︎
All You Need to Know about Biologics - How They Work, When to Use Them and The Common Side Effects
▶︎
Unraveling the Mysteries of Depression
▶︎
Tuberculosis | Clinical Medicine
▶︎
Psoriasis Uncovered: Progress Towards Identifying a Psoriatic Arthritis Diagnostic Test
▶︎
Keeping Up with IBS Treatment Strategies
▶︎
The Complete Cardiology Masterclass: Exam-Ready in One Video
▶︎